WELL Health Technologies Corp. WELL

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. ("WELLSTAR") has completed the previously announced amalgamation (the "Transaction") with 1587818 B.C. Ltd. ("818"). The entity.

WELLSTAR has received conditional approval from the TSX Venture Exchange as a Tier 1 issuer, subject to satisfaction of the TSXV's customary listing conditions, and is expected to commence trading on or around October 1, 2026, under the ticker symbol "WSTR".Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to...

WELL Research is the clinical research brand of WELL Health Technologies. WELL Research offers the unique combination of full-service contract research organization (CRO) services in early-phase trials, site management organization (SMO) execution at late-stage trial sites, and bioanalytical services across every phase of clinical trials. Together, these capabilities span the full clinical trial value chain and allow sponsors and providers to enrol the right trial participants quickly and...

WELL has appointed Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026. Ms. Sutherland brings more than 20 years of senior financial leadership experience, including CFO roles at Staples Canada, Enercare Inc., KEYreit, and United Purchasing Group of Canada (Yum! Brands).Ms. Sutherland has served on the Board of WELL's subsidiary, WELLSTAR, over the past year and brings direct knowledge of the Company's strategy, governance and culture to the role.Eva Fong, WELL's...

WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to be contacted about clinical trials and research studies matched to their health circumstances. HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching trial

WELL Health redeemed early all of its outstanding 5.50% convertible senior unsecured debentures on August 19, 2026.Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, redeemed early all of its outstanding 5.50% convertible senior...

WELL Health Technologies (TSE:WELL) reported second-quarter revenue of approximately C$404 million, up 12% from a year earlier, while adjusted EBITDA was C$48.1 million, down 3% on a reported basis. The company raised its full-year 2026 adjusted EBITDA outlook by C$10 million, citing stronger execut

Earnings event puts WELL Health Technologies under the microscope WELL Health Technologies (TSX:WELL) has stepped into the spotlight after reporting second quarter 2026 results that paired record quarterly revenue with a move from profit to loss. The company posted Q2 sales of CA$400.43 million compared with CA$356.67 million a year earlier, while net results shifted from income of CA$12.15 million to a net loss of CA$10.91 million. On a per share basis, basic and diluted loss from continuing...

WELL Health Technologies stock has delivered a steep decline of about 48.4% over the past 5 years, yet current valuation checks give a mixed reading rather than a clear bargain or clear overvaluation story. Recent news highlights record revenue milestones and new leadership hires, so investors are weighing that progress against a share price that has not kept pace. The share price is down roughly 48.4% over 5 years, which suggests long term holders have faced meaningful capital losses even...

WELL achieved quarterly revenues of $400.4 million in Q2-2026, an increase of 12% as compared to Q2-2025, driven by strong growth in the Company's Canadian Patient Services Business where quarterly revenue increased by 32% to $151.6 million in Q2-2026 as compared to Q2-2025.WELL achieved Adjusted EBITDA(1) of $48.1 million in Q2-2026, a decrease of 3% as compared to Q2-2025, representing an Adjusted EBITDA Margin(1) of 12%. The decrease reflects the impact of Circle Medical Deferrals(2) which...

WELL appoints accomplished legal and business executive Loreto Grimaldi as Chief Legal Officer to lead legal, compliance, governance, risk management and M&A activities across the organization.Seasoned technology and digital transformation leader Kaytek Przybylski joins WELL as Chief Digital & Information Officer to lead enterprise technology, digital transformation, data, AI, and cybersecurity and technology shared services strategy.Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026)

Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal Second Quarter 2026 financial results for the period ended June 30, 2026, after market close on Thursday, August 6,...

Vancouver, British Columbia--(Newsfile Corp. - July 31, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. ("WELLSTAR"), has closed a financing transaction for aggregate gross proceeds of C$50 million (the "Financing"), consisting of C$36.2

Vancouver, British Columbia--(Newsfile Corp. - July 15, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, announces it has closed its previously announced inaugural private placement offering (the "Offering") of $150 million aggregate principal amount of 6.875% senior unsecured notes due July.

WELL has priced its inaugural offering of $150 million of senior unsecured notes due 2031, bearing interest at 6.875% per annum.Net proceeds will be used to fully repay WELL's convertible debentures due December 2026 and for general corporate purposes.The Offering extends WELL's debt maturity profile to 2031 and strengthens the Company's balance sheet to support continued growth in Canada.All amounts in Canadian dollars unless otherwise statedVancouver, British Columbia--(Newsfile Corp. - July..

WELL Health Technologies (WELL.TO) on Tuesday said its subsidiary Wellstar Technologies, will amalga

Vancouver, British Columbia--(Newsfile Corp. - June 17, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that at its annual general and special meeting held June 16, 2026 (the "Meeting"), all of the nominees for election as directors of the Company referred to in its...

WELL Health Technologies (WELL.TO) reported last Friday that a billing investigation involving Circ

WELL Health is providing a corporate update on its majority-owned subsidiary Circle Medical, a leading telehealth platform delivering accessible, insurance-based primary care across the United States.Circle Medical continues to expand access to care, having more than tripled the number of commercially insured patients eligible to receive care on its platform over the last year, supported by strong double-digit growth in new patient bookings and activations in May 2026 as compared to May 2025.As.

WELL Health Technologies has appointed Dr. Andrew Bond as Chief Health Officer and Head of Public Sector, and Derek Clark as Chief Operating Officer, adding experienced leadership to clinical governance, government engagement, and platform-wide operations. These hires deepen WELL’s bench in both health system policy and complex multi-entity execution, reinforcing its push to work more closely with public health systems while scaling its national digital and clinic network. Next, we’ll...